Cargando…
Enzyme-Loaded Gel Core Nanostructured Lipid Carriers to Improve Treatment of Lysosomal Storage Diseases: Formulation and In Vitro Cellular Studies of Elosulfase Alfa-Loaded Systems
Mucopolysaccharidosis IVA (Morquio A) is a rare inherited metabolic disease caused by deficiency of the lysosomal enzyme N-acetylgalatosamine-6-sulfate-sulfatase (GALNS). Until now, treatments employed included hematopoietic stem cell transplantation and enzyme replacement therapy (ERT); the latter...
Autores principales: | Álvarez, J. Víctor, Herrero Filgueira, Carolina, González, Alexandre de la Fuente, Colón Mejeras, Cristóbal, Beiras Iglesias, Andrés, Tomatsu, Shunji, Blanco Méndez, José, Luzardo Álvarez, Asteria, Couce, María Luz, Otero Espinar, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835858/ https://www.ncbi.nlm.nih.gov/pubmed/31614479 http://dx.doi.org/10.3390/pharmaceutics11100522 |
Ejemplares similares
-
Proteomic Analysis in Morquio A Cells Treated with Immobilized Enzymatic Replacement Therapy on Nanostructured Lipid Systems
por: Álvarez, J. Víctor, et al.
Publicado: (2019) -
Development, Characterization, and In Vitro Evaluation of Resveratrol-Loaded Poly-(ε-caprolactone) Microcapsules Prepared by Ultrasonic Atomization for Intra-Articular Administration
por: Luzardo-Álvarez, Asteria, et al.
Publicado: (2019) -
Role of elosulfase alfa in mucopolysaccharidosis IVA
por: Regier, Debra S, et al.
Publicado: (2016) -
The Application of Microencapsulation Techniques in the Treatment of Endodontic and Periodontal Disease
por: Álvarez, Asteria Luzardo, et al.
Publicado: (2011) -
Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A Syndrome
por: Lee, Chung-Lin, et al.
Publicado: (2022)